ArticleCardiovascular diabetology2022

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists.

Kosuke Sawami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.